FO

FT Options Portfolio holdings

AUM $40M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+18.48%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$40M
AUM Growth
-$712K
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
144
New
Increased
Reduced
Closed

Top Buys

1
+$3.53M
2
+$2.94M
3
+$2.18M
4
ARAV
Aravive, Inc. Common Stock
ARAV
+$1.54M
5
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
+$1.37M

Top Sells

1
+$2.52M
2
+$2.31M
3
+$2.08M
4
ABT icon
Abbott
ABT
+$1.72M
5
CLVS
Clovis Oncology, Inc.
CLVS
+$1.56M

Sector Composition

1 Healthcare 69.4%
2 Consumer Discretionary 11.79%
3 Consumer Staples 10.38%
4 Communication Services 1.65%
5 Materials 0.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
POT
51
DELISTED
Potash Corp Of Saskatchewan
POT
$121K 0.3%
6,300
-33,780
FCSC
52
DELISTED
Fibrocell Science Inc.
FCSC
$116K 0.29%
+7,600
LRMR icon
53
Larimar Therapeutics
LRMR
$426M
$90K 0.23%
2,138
-2,951
SVVC
54
DELISTED
Firsthand Technology Value Fund, Inc. Common Stock
SVVC
$88K 0.22%
11,000
-9,000
TTPH
55
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$82K 0.21%
+600
HAIN icon
56
Hain Celestial
HAIN
$70.7M
$74K 0.19%
1,800
-8,200
PRTK
57
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$69K 0.17%
+2,748
CL icon
58
Colgate-Palmolive
CL
$78.2B
$66K 0.17%
900
-12,847
ZSAN
59
DELISTED
Zosano Pharma Corporation
ZSAN
$49K 0.12%
86
JUNO
60
DELISTED
Juno Therapeutics, Inc.
JUNO
$45K 0.11%
+1,000
RCKT icon
61
Rocket Pharmaceuticals
RCKT
$555M
$36K 0.09%
5,000
-32,500
GGP
62
DELISTED
GGP Inc.
GGP
$36K 0.09%
+1,757
MOS icon
63
The Mosaic Company
MOS
$9.09B
$20K 0.05%
+933
CCEP icon
64
Coca-Cola Europacific Partners
CCEP
$49B
$4K 0.01%
+100
A icon
65
Agilent Technologies
A
$33.7B
– –
-3,236
KATE
66
DELISTED
Kate Spade & Company
KATE
– –
-300
IONS icon
67
Ionis Pharmaceuticals
IONS
$13.1B
– –
0
ACAD icon
68
Acadia Pharmaceuticals
ACAD
$4.11B
– –
0
AER icon
69
AerCap
AER
$24.1B
– –
0
AKBA icon
70
Akebia Therapeutics
AKBA
$342M
– –
-30
ALNY icon
71
Alnylam Pharmaceuticals
ALNY
$43.9B
– –
-2,938
AMGN icon
72
Amgen
AMGN
$209B
– –
-12,082
AZN icon
73
AstraZeneca
AZN
$319B
– –
0
BCRX icon
74
BioCryst Pharmaceuticals
BCRX
$2.17B
– –
-11,240
BHC icon
75
Bausch Health
BHC
$2.12B
– –
0
1 2
3
4 5